With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
NEW YORK (Reuters Health) – For asymptomatic bacteriuria in pregnant women, a 1-day regimen of nitrofurantoin is significantly less effective than the standard 7-day regimen, results of a…
NEW YORK (Reuters Health) – In a year-long study conducted in Dallas County Texas, women who called 911 for suspected cardiac-related symptoms had a 52% greater likelihood of…
A new procedure, laparoscopic hysterectomy, means there’s no reason for a woman to undergo an invasive abdominal hysterectomy unless she has a severe medical problem. ~ Detroit Medical…
NEW YORK (Reuters Health) – Treatment with the nonsteroidal selective estrogen receptor modulator raloxifene may heighten the risk of venous thromboembolic events and stroke deaths in postmenopausal women…
NEW YORK (Reuters Health) – Long-term follow-up after laparoscopic supracervical hysterectomy shows that while many women continue to experience vaginal bleeding and pelvic pain, these symptoms are not…
NEW YORK (Reuters Health) – Elective repeat cesarean delivery at term but before 39 weeks is associated with higher rates of adverse outcomes, physicians in the US report…
This video discusses recent studies that show a correlation between hysterectomy surgery and eventual stress-urinary incontinence surgery. References and Resources Magos, A. Does hysterectomy cause urinary incontinence?. The…
Use of skin cells to create pluripotent stem cells that look and act like embryonic stem cells have been discovered. References and Resources Takahashi K, Tanabe K, Ohnuki…
In an article published in July 9, 2009 issue of The New England Journal of Medicine, Dr. Daniel Clarke-Pearson, chair of the department of obstetrics and gynecology at…
Chad Deal, MD, Rheumatologist, Head, Center for Osteoporosis and Metabolic Bone Disease, Cleveland Clinic, discusses a new antiresorptive agent for osteoporosis, denosumab, a fully human monoclonal antibody that…
